Our Immune Systems Can be Used to Battle Against Cancer
In recent years, a new generation of cancer drugs has been developed that blocks proteins that inhibit immune activity against malignant tumors. These drugs have shown remarkable success in several tumor types.
(Israel) – Unknown to us all, there is a battle raging constantly in our bodies every minute. Our immune system – consisting of macrophages, neutrophils, dendritic cells, natural-killer cells, neutrophils, mast cells, basophils and B cells in the blood – is a biological machine aimed at protecting us from invaders.
These cells aim to kill bacteria or viruses and defend our bodies against disease and infection, storing data about these pathogens so they can identify and attack them again should they launch another attack.
But how about cancer – cells that undergo mutations and grow uncontrollably? There is an enduring debate on whether a main function of the immune system is to prevent cancer. The concept of immunological surveillance of cancer was developed by Lewis Thomas and Frank Macfarlane Burnet more than half-a-century ago.
Experts maintain that if none of us had an immune system, we would all get cancer. Fortunately, this doesn’t happen, but …
Click here to continue reading.